Option Care Health, Inc. (NASDAQ:OPCH – Get Free Report) saw unusually-strong trading volume on Wednesday. Approximately 2,914,495 shares were traded during trading, an increase of 5% from the previous session’s volume of 2,766,312 shares. The stock last traded at $31.0050 and had previously closed at $31.00.
Key Stories Impacting Option Care Health
Here are the key news stories impacting Option Care Health this week:
- Positive Sentiment: CD&R and McKesson agreed to acquire Option Care Health for $32.05 per share in cash, representing a 37% premium to the prior closing price and an implied enterprise value of approximately $5.8 billion. The transaction provides shareholders with a defined cash exit and was the primary catalyst for the stock’s surge. CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health
- Positive Sentiment: Unusually heavy call-option activity—5,219 contracts purchased versus typical daily volume of 281—signals elevated speculative interest following the buyout announcement, although it does not guarantee further gains.
- Neutral Sentiment: Citizens JMP and Barrington Research both reaffirmed “Market Perform” ratings. These ratings are less relevant after the proposed take-private transaction but indicate neither firm issued a stronger bullish view. Option Care Health Stock Rating Reaffirmed
- Neutral Sentiment: Recent operating results were solid, with quarterly EPS of $0.45 exceeding the $0.43 consensus estimate and revenue of $1.44 billion topping expectations. However, the buyout terms now matter more to investors than standalone earnings prospects.
- Negative Sentiment: Shares remain below the $32.05 offer price, creating a deal spread that reflects potential risks involving regulatory approval, shareholder approval, financing, or failure to close. Option Care Stock Trades Below McKesson’s Deal Price
- Negative Sentiment: Several investor-rights law firms are investigating whether the $32.05 price fairly values Option Care Health and whether insiders received benefits unavailable to public shareholders. Such reviews could create litigation, delays, or pressure to improve the offer, though they do not necessarily indicate wrongdoing. Ademi LLP Option Care Health Shareholder Alert
Wall Street Analysts Forecast Growth
A number of equities analysts recently issued reports on the company. Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and raised their price target for the stock from $28.00 to $32.05 in a report on Tuesday. Barrington Research reiterated a “market perform” rating on shares of Option Care Health in a research note on Wednesday. Weiss Ratings raised Option Care Health from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, September 11th. Citizens Jmp reaffirmed a “market perform” rating on shares of Option Care Health in a report on Wednesday. Finally, Wall Street Zen upgraded shares of Option Care Health from a “hold” rating to a “buy” rating in a research report on Saturday, August 1st. Four equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $29.70.
Option Care Health Price Performance
The company has a market capitalization of $4.65 billion, a price-to-earnings ratio of 23.35, a PEG ratio of 1.35 and a beta of 0.58. The company has a current ratio of 1.47, a quick ratio of 0.98 and a debt-to-equity ratio of 0.91. The company’s 50 day simple moving average is $23.78 and its 200-day simple moving average is $23.55.
Option Care Health (NASDAQ:OPCH – Get Free Report) last released its earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.02. The firm had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.42 billion. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%.The firm’s revenue for the quarter was up 1.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.41 earnings per share. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. On average, equities research analysts predict that Option Care Health, Inc. will post 1.7 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Option Care Health
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Harbor Investment Advisory LLC bought a new position in shares of Option Care Health during the second quarter worth about $48,000. Nykredit A S acquired a new stake in Option Care Health during the second quarter valued at approximately $56,000. Public Employees Retirement System of Ohio acquired a new stake in Option Care Health during the second quarter valued at approximately $66,000. KBC Group NV lifted its holdings in Option Care Health by 22.1% during the 1st quarter. KBC Group NV now owns 5,453 shares of the company’s stock worth $147,000 after buying an additional 988 shares during the last quarter. Finally, Summitry LLC bought a new position in Option Care Health during the 1st quarter worth approximately $200,000. 98.05% of the stock is owned by hedge funds and other institutional investors.
Option Care Health Company Profile
Option Care Health, Inc (NASDAQ: OPCH) is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver and manage infusion therapy outside traditional hospital settings, including in patients’ homes, ambulatory infusion suites and other community-based locations.
Its services include the provision and administration of specialty medications and other infusion therapies for conditions such as infections, immune disorders, chronic diseases and nutritional deficiencies.
Featured Articles
- Five stocks we like better than Option Care Health
- Disney Is Opening the Door to Netflix—and Changing the Streaming Playbook
- DraftKings Stacks the Deck: The $800M Prediction Pivot
- Wall Street Is Betting These 3 Beaten-Down Stocks Have More Room to Run
- Marvell Technology’s $90 Billion Revenue Goal Puts AI Execution Under a Microscope
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.
